Showing results (151-160 of 251) with videos related to
Sort By:
Pageof 26
The American Journal of Psychiatry|October 10, 1998
Dopamine D2 receptor density and personal detachment in healthy subjectsA Breier, L Kestler, C Adler, et al.The American Journal of Psychiatry|June 1, 1995
Patient response and resource management: another view of clozapine treatment of schizophreniaW T Carpenter, R R Conley, R W Buchanan, et al.General Physiology and Biophysics|March 16, 2007
Structural differences between sensitive and resistant L1210 cellsB Uhrík, A H El-Saggan, M Seres, et al.The American Journal of Psychiatry|January 1, 1986
Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophreniaO M Wolkowitz, D Pickar, A R Doran, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2000
Measurement of dopamine release with continuous infusion of [11C]raclopride: optimization and signal-to-noise considerationsH Watabe, C J Endres, A Breier, et al.Nature Communications|November 18, 2015
Genomic and transcriptomic evidence for scavenging of diverse organic compounds by widespread deep-sea archaeaMeng Li, Brett J Baker, Karthik Anantharaman, et al.Life Sciences|October 19, 1987
Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illnessO M Wolkowitz, D R Rubinow, A Breier, et al.General Physiology and Biophysics|November 5, 2008
Overexpression of P-glycoprotein in L1210/VCR cells is associated with changes in several endoplasmic reticulum proteins that may be partially responsible for the lack of thapsigargin sensitivityM Seres, E Poláková, O Krizanová, et al.Archives of General Psychiatry|October 1, 1994
Neuropsychological impairments in deficit vs nondeficit forms of schizophreniaR W Buchanan, M E Strauss, B Kirkpatrick, et al.The Journal of Physical Chemistry. A|April 25, 2023
Ro-vibrational Spectrum of Linear Dialuminum Monoxide (Al2O) at 10 μmDaniel Witsch, Eileen Döring, Alexander A Breier, et al.Pageof 26